-
Mashup Score: 25
Brain-computer interfaces (BCIs) show enormous potential for advancing personalized medicine. However, BCIs also introduce new avenues for cyber-attacks or secu
Source: papers.ssrn.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Defining Sex in Law - 12 day(s) ago
This paper explores the meaning of the term “sex” in law. It distinguishes between indeterminate sex and attempts to change sex, by tracing caselaw of
Source: papers.ssrn.comCategories: General Medicine News, Hem/OncsTweet-
Defining sex in law https://t.co/gtEam4Iatf via @michaelpforan https://t.co/zF6nra3jhq
-
-
Mashup Score: 31AI as Legal Persons: Past, Patterns, and Prospects - 14 day(s) ago
This paper examines the debate on AI legal personhood, emphasizing the role of path dependencies in shaping current trajectories and prospects. Three p
Source: papers.ssrn.comCategories: General Medicine News, Future of MedicineTweet-
RT @bimedotcom: AI as Legal Persons: Past, Patterns, and Prospects https://t.co/mYy1p3kYUN ✍️@novelli_claudio, Luciano Floridi, @GiovanniS…
-
-
Mashup Score: 5
Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP
Source: papers.ssrn.comCategories: General Medicine News, Hem/OncsTweet-
Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial {Pre-print} [Nov 9, 2024] Hoffmann et al. @TheLancet https://t.co/Txy4v1GCRP #NCT05271929 #COVID19CP #COVID19
-
-
Mashup Score: 5
Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP
Source: papers.ssrn.comCategories: General Medicine News, Hem/OncsTweet-
Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial {Pre-print} [Nov 9, 2024] Hoffmann et al. @TheLancet https://t.co/Txy4v1GCRP #NCT05271929 #COVID19CP #COVID19
-
-
Mashup Score: 6The scientific mission and governance of an Intergovernmental Panel on Pandemics: lessons from the IPCC and IPBES - 2 month(s) ago
Pandemics pose a global threat to human-wellbeing, justice, economies, and ecosystems, comparable in urgency and impact to other planetary cris
Source: papers.ssrn.comCategories: General Medicine News, Infectious DiseaseTweet-
Plea for an intergovernmental panel on pandemics https://t.co/e4U0jHQrji
-
-
Mashup Score: 18The First Observational Study on Clade Ib Mpox Transmission and Disease Severity in South Kivu - 2 month(s) ago
Background: Mpox is a re-emerging zoonotic disease in Africa, with increasing cases attributed to the newly identified Clade Ib variant. This outbreak started i
Source: papers.ssrn.comCategories: General Medicine News, Infectious DiseaseTweet-
Another preprint from our collaboration: description of 100 cases of Clade Ib mpox https://t.co/oAWCddNgv0 Symptoms by age and suspected mode of transmission, and duration of illness. CRF from ISARIC, study lead by Prof Trudi Lang and local scientist Leandre Murhula Masirika https://t.co/pVwvBzhdx2
-
-
Mashup Score: 4
We develop a supply-and-demand equilibrium framework and model to forecast Bitcoin’s price trajectory. Grounded in economic first principles, the model integrat
Source: papers.ssrn.comCategories: General Medicine News, General HCPsTweet-
RT @JohnNosta: 🔥"Bitcoin price could exceed $1,000,000 by 2027." https://t.co/i8jg3vUcKg #Bitcoin @@CathieDWood @BrianRoemmele @saylor @B…
-
-
Mashup Score: 2The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Purchases - 2 month(s) ago
We examine how consumers modify their food purchasing behavior after adopting appetite-suppressing GLP-1 receptor agonists, such as Ozempic and Wegovy. Utilizin
Source: papers.ssrn.comCategories: General Medicine News, General HCPsTweet-
Study: “The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Purchased” https://t.co/6DUdyYvZgB ht @margrev
-
-
Mashup Score: 5
Background: COVID-19 convalescent plasma (CCP) is a treatment option for COVID-19. This study investigated the safety and efficacy of early, very high-titre CCP
Source: papers.ssrn.comCategories: General Medicine News, Hem/OncsTweet-
Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial {Pre-print} [Nov 9, 2024] Hoffmann et al. @TheLancet https://t.co/Txy4v1GCRP #NCT05271929 #COVID19CP #COVID19
-
RT @bimedotcom: Cyber Risks to Next-Gen Brain-Computer Interfaces: Analysis and Recommendations https://t.co/EuFRykXPN9 ✍️Tyler Schroder,…